专栏名称: 毕凯今选
由毕凯医药为您每周跟踪PUBMED十大瘤种最新前沿进展,编译制作,每日分享推送,希望我们的一点点绵薄之力,能为临床助力,做医生的朋友,做患者的帮助!
今天看啥  ›  专栏  ›  毕凯今选

【其他高分选 076】

毕凯今选  · 公众号  ·  · 2024-11-21 15:06
    

文章预览

BC PMID: 39551726 IF:27.7 Uncovering the predictive and immunomodulatory potential of transient receptor potential melastatin family-related CCNE1 in pan-cancer SCI:Mol Cancer PMID:39555704 IF:14.3 Precise HER2 Protein Degradation via Peptide-Conjugated Photodynamic Therapy for Enhanced Breast Cancer Immunotherapy SCI:Adv Sci (Weinh) PMID:39552584 IF:11.7 Mitochondrial elongation impairs breast cancer metastasis SCI:Sci Adv PMID:39557612 IF:16.1 Rapid, Non-Invasive, Accurate Diagnosis and Efficient Clearance of Metastatic Lymph Nodes SCI:Angew Chem Int Ed Engl PMID:39557820 IF:14.7 Generation of chimeric antigen receptor T cells targeting p95HER2 in solid tumors SCI:Nat Commun PMID:39558215 IF:10.4 Integrated single-cell analysis reveals distinct epigenetic-regulated cancer cell states and a heterogeneity-guided core signature in tamoxifen-resistant breast cancer SCI:Genome Med PMID:39560480 IF:12.1 Deep Learning Algorithms for Breast Cancer Detection in a UK Screening Cohort: As Stand ………………………………

原文地址:访问原文地址
快照地址: 访问文章快照
总结与预览地址:访问总结与预览